Skip to content

Flexible Band vs Rigid Ring for Degenerative Mitral Valve Disease

Mitral Valve Repair Using Flexible Bands Versus Complete Rings in Patients With Degenerative Mitral Valve Disease: a Prospective, Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03278574
Enrollment
171
Registered
2017-09-11
Start date
2011-09-05
Completion date
2016-12-26
Last updated
2017-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitral Regurgitation

Brief summary

The study evaluates the results of mitral valve repair with flexible band in comparison with rigid ring in patients undergoing mitral valve repair for degenerative mitral valve disease

Detailed description

Currently, mitral ring selection is based on a surgeon's preference rather than evidence. Semirigid rings combine flexibility and stability; however, their clinical benefit has not been completely clarified. The present study aimed to compare the outcomes of mitral valve repair with a flexible posterior annuloplasty band versus complete semirigid ring in patients with degenerative mitral valve disease.

Interventions

Mitral valve repair with standard technique: resection of prolapsed leaflet and/or artificial neochordae implantation

DEVICERing annuloplasty with posterior band

Mitral valve annuloplasty using Cardiamed (Penza, Russia) flexible posterior annuloplasty band

DEVICERing annuloplasty with complete ring

Mitral valve annuloplasty using Cardiamed (Penza, Russia) complete semirigid ring

Sponsors

Meshalkin Research Institute of Pathology of Circulation
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* severe primary mitral regurgitation due to degenerative mitral valve disease

Exclusion criteria

* previous open cardiac surgery, * indication for concomitant aortic valve replacement, * left ventricle impairment (ejection fraction \< 40%).

Design outcomes

Primary

MeasureTime frameDescription
Freedom from significant mitral regurgitation12 monthsSignificant mitral regurgitation is defined as moderate and severe mitral regurgitation. The severity of MR was evaluated and defined in accordance with the European Association of Echocardiography recommendations for the assessment of valvular regurgitation

Secondary

MeasureTime frameDescription
Survival12 months, 24 monthsContinued existence at follow up
Freedom from reoperations12 months, 24 monthsFreedom from redo mitral valve surgery during follow up
Freedom from severe MR recurrence12 monthsThe severity of MR was evaluated and defined in accordance with the European Association of Echocardiography recommendations for the assessment of valvular regurgitation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026